Legal Representation
Attorney
Bridget H. Labutta
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 25, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 25, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 25, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 2, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 2, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 2, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 31, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 31, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 13, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 13, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 13, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 5, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 5, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 5, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 5, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 5, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 17, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 16, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 16, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 10, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 25, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 25, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 25, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 15, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 11, 2020 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 11, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 19, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 17, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 17, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 13, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 11, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 11, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 21, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 19, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 19, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 19, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 10, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 10, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 25, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 30, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 30, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 10, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 23, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 8, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 8, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 8, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"